111 related articles for article (PubMed ID: 21305698)
1. A strategy for neuraminidase inhibitors using mechanism-based labeling information.
Hinou H; Miyoshi R; Takasu Y; Kai H; Kurogochi M; Arioka S; Gao XD; Miura N; Fujitani N; Omoto S; Yoshinaga T; Fujiwara T; Noshi T; Togame H; Takemoto H; Nishimura S
Chem Asian J; 2011 Apr; 6(4):1048-56. PubMed ID: 21305698
[TBL] [Abstract][Full Text] [Related]
2. Aglycone-focused randomization of 2-difluoromethylphenyl-type sialoside suicide substrates for neuraminidases.
Kai H; Hinou H; Nishimura S
Bioorg Med Chem; 2012 Apr; 20(8):2739-46. PubMed ID: 22410247
[TBL] [Abstract][Full Text] [Related]
3. Macrocyclic mechanism-based inhibitor for neuraminidases.
Kai H; Hinou H; Naruchi K; Matsushita T; Nishimura S
Chemistry; 2013 Jan; 19(4):1364-72. PubMed ID: 23233350
[TBL] [Abstract][Full Text] [Related]
4. Characterization of Vibrio cholerae neuraminidase by a novel mechanism-based fluorescent labeling reagent.
Hinou H; Kurogochi M; Shimizu H; Nishimura S
Biochemistry; 2005 Sep; 44(35):11669-75. PubMed ID: 16128567
[TBL] [Abstract][Full Text] [Related]
5. Synthesis of selective inhibitors against V. cholerae sialidase and human cytosolic sialidase NEU2.
Khedri Z; Li Y; Cao H; Qu J; Yu H; Muthana MM; Chen X
Org Biomol Chem; 2012 Aug; 10(30):6112-20. PubMed ID: 22641268
[TBL] [Abstract][Full Text] [Related]
6. The use of a quantitative fusion assay to evaluate HN-receptor interaction for human parainfluenza virus type 3.
Levin Perlman S; Jordan M; Brossmer R; Greengard O; Moscona A
Virology; 1999 Dec; 265(1):57-65. PubMed ID: 10603317
[TBL] [Abstract][Full Text] [Related]
7. Three-dimensional structure of influenza A N9 neuraminidase and its complex with the inhibitor 2-deoxy 2,3-dehydro-N-acetyl neuraminic acid.
Bossart-Whitaker P; Carson M; Babu YS; Smith CD; Laver WG; Air GM
J Mol Biol; 1993 Aug; 232(4):1069-83. PubMed ID: 8371267
[TBL] [Abstract][Full Text] [Related]
8. Multivalency and the mode of action of bacterial sialidases.
Thobhani S; Ember B; Siriwardena A; Boons GJ
J Am Chem Soc; 2003 Jun; 125(24):7154-5. PubMed ID: 12797770
[TBL] [Abstract][Full Text] [Related]
9. One-bead-one-inhibitor-one-substrate screening of neuraminidase activity.
Ying L; Gervay-Hague J
Chembiochem; 2005 Oct; 6(10):1857-65. PubMed ID: 16149103
[TBL] [Abstract][Full Text] [Related]
10. Inhibition studies on Vibrio cholerae neuraminidase.
Brossmer R; Keilich G; Ziegler D
Hoppe Seylers Z Physiol Chem; 1977 Mar; 358(3):391-6. PubMed ID: 856712
[TBL] [Abstract][Full Text] [Related]
11. Saturation transfer difference (STD) 1H-NMR experiments and in silico docking experiments to probe the binding of N-acetylneuraminic acid and derivatives to Vibrio cholerae sialidase.
Haselhorst T; Wilson JC; Thomson RJ; McAtamney S; Menting JG; Coppel RL; von Itzstein M
Proteins; 2004 Aug; 56(2):346-53. PubMed ID: 15211517
[TBL] [Abstract][Full Text] [Related]
12. Triazole-linked transition state analogs as selective inhibitors against V. cholerae sialidase.
Slack TJ; Li W; Shi D; McArthur JB; Zhao G; Li Y; Xiao A; Khedri Z; Yu H; Liu Y; Chen X
Bioorg Med Chem; 2018 Nov; 26(21):5751-5757. PubMed ID: 30389408
[TBL] [Abstract][Full Text] [Related]
13. Potent inhibitor scaffold against Trypanosoma cruzi trans-sialidase.
Arioka S; Sakagami M; Uematsu R; Yamaguchi H; Togame H; Takemoto H; Hinou H; Nishimura S
Bioorg Med Chem; 2010 Feb; 18(4):1633-40. PubMed ID: 20097567
[TBL] [Abstract][Full Text] [Related]
14. Characteristic of neuraminidase inhibitory xanthones from Cudrania tricuspidata.
Ryu YB; Curtis-Long MJ; Lee JW; Kim JH; Kim JY; Kang KY; Lee WS; Park KH
Bioorg Med Chem; 2009 Apr; 17(7):2744-50. PubMed ID: 19285413
[TBL] [Abstract][Full Text] [Related]
15. Design and synthesis of novel imidazole-substituted dipeptide amides as potent and selective inhibitors of Candida albicans myristoylCoA:protein N-myristoyltransferase and identification of related tripeptide inhibitors with mechanism-based antifungal activity.
Devadas B; Freeman SK; Zupec ME; Lu HF; Nagarajan SR; Kishore NS; Lodge JK; Kuneman DW; McWherter CA; Vinjamoori DV; Getman DP; Gordon JI; Sikorski JA
J Med Chem; 1997 Aug; 40(16):2609-25. PubMed ID: 9258368
[TBL] [Abstract][Full Text] [Related]
16. Sialic acid recognition by Vibrio cholerae neuraminidase.
Moustafa I; Connaris H; Taylor M; Zaitsev V; Wilson JC; Kiefel MJ; von Itzstein M; Taylor G
J Biol Chem; 2004 Sep; 279(39):40819-26. PubMed ID: 15226294
[TBL] [Abstract][Full Text] [Related]
17. Prenylated pterocarpans as bacterial neuraminidase inhibitors.
Nguyen PH; Nguyen TN; Kang KW; Ndinteh DT; Mbafor JT; Kim YR; Oh WK
Bioorg Med Chem; 2010 May; 18(9):3335-44. PubMed ID: 20363636
[TBL] [Abstract][Full Text] [Related]
18. Highly potent and long-acting trimeric and tetrameric inhibitors of influenza virus neuraminidase.
Watson KG; Cameron R; Fenton RJ; Gower D; Hamilton S; Jin B; Krippner GY; Luttick A; McConnell D; MacDonald SJ; Mason AM; Nguyen V; Tucker SP; Wu WY
Bioorg Med Chem Lett; 2004 Mar; 14(6):1589-92. PubMed ID: 15006410
[TBL] [Abstract][Full Text] [Related]
19. Novel aromatic inhibitors of influenza virus neuraminidase make selective interactions with conserved residues and water molecules in the active site.
Finley JB; Atigadda VR; Duarte F; Zhao JJ; Brouillette WJ; Air GM; Luo M
J Mol Biol; 1999 Nov; 293(5):1107-19. PubMed ID: 10547289
[TBL] [Abstract][Full Text] [Related]
20. Design, synthesis, and biological evaluation of human sialidase inhibitors. Part 1: selective inhibitors of lysosomal sialidase (NEU1).
Magesh S; Moriya S; Suzuki T; Miyagi T; Ishida H; Kiso M
Bioorg Med Chem Lett; 2008 Jan; 18(2):532-7. PubMed ID: 18068975
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
